Sort
17,828 grants matching “crispr”
Engineering commensal bacteria and probiotics for lactate conversion and treatment of sepsis
$75,520Noah Thomas Hutchinson · University Of Michigan At Ann Arbor · F32 · FY2025 · AI
Precision Deaminases to Expand the Scope of Diseases Amenable to CRISPR-mediated Correction
$75,520Erin E Doherty · University Of California Berkeley · F32 · FY2025 · GM
Suppressing HIV infection by disrupting CCR5 with double nicking CRISPR-Cas9 syst
$75,500Haoquan Wu · Texas Tech University Health Scis Center · R03 · FY2015 · AI
Suppressing HIV infection by disrupting CCR5 with double nicking CRISPR-Cas9 syst
$75,500Haoquan Wu · Texas Tech University Health Scis Center · R03 · FY2014 · AI
Mechanisms of Sequence-Based Resistance to Viruses and Plasmids in Eubacteria
$75,488Erik J Sontheimer · Northwestern University · R03 · FY2010 · AI
The role of gene enhancer elements in colon cancer
$75,480Peter Christopher Scacheri · Case Western Reserve University · R01 · FY2021 · CA
Research Projects #1 and #2
$75,403Kc Kent Lloyd · University Of California At Davis · U42 · FY2021 · OD
Developing animal models to dissociate lysosomal from inflammatory functions of acid sphingomyelinase
$75,356Ashley Jones Snider · University Of Arizona · R03 · FY2019 · HD
MegaTALS: hyperspecific reagents for targeted gene modification and correction
$75,286Barry L. Stoddard · Fred Hutchinson Cancer Research Center · R01 · FY2022 · GM
Research Projects #1 and #2
$75,198Kc Kent Lloyd · University Of California At Davis · U42 · FY2022 · OD
Characterization of a Novel lncRNA in Breast Cancer
$75,130Kirsten Tracy · University Of Vermont & St Agric College · F32 · FY2021 · CA
Waking up the nervous system: Molecular characterization of neuronal leader cells and their role in brain development
$75,110Nicole Ann Aponte-Santiago · University Of California, San Francisco · F32 · FY2021 · MH
Genomic Analysis of Nucleic Acid Transactions
$75,100Brenton R Graveley · University Of Connecticut Sch Of Med/Dnt · R35 · FY2021 · GM
Targeting TRAPPC11 as a therapeutic in inherited dilated cardiomyopathy
$75,052Sarah Louise Sturgill · Stanford University · F32 · FY2025 · HL
Exploring leaderless mRNA translation, a potential Achilles heel of mycobacteria
$75,052Sarah C Feid · University Of California, San Francisco · F32 · FY2025 · AI
KOMP2 UM1 Administrative Supplement Request to support Early Stage Knockout Mouse Embryonic Phenotyping
$75,001Paul Flicek · European Molecular Biology Laboratory · UM1 · FY2019 · HG
Elucidating the role of the SAGA complex in MYCN-amplified neuroblastoma
$74,886Clare Felicity Malone · Dana-Farber Cancer Inst · F32 · FY2021 · CA
Targeting MCL-1 dependent apoptotic vulnerability of KRAS-LKB1 NSCLC
$74,886Chendi Li · Massachusetts General Hospital · F32 · FY2021 · CA
Obesity in ciliopathies: How neuronal primary cilia control appetite
$74,619Christian Vaisse · University Of California, San Francisco · R01 · FY2024 · DK
Defining gene-by-environment interactions using multiplex single-cell genomics
$74,559Jose Luis McFaline-Figueroa · Columbia Univ New York Morningside · R35 · FY2023 · HG
Sequence-Specific CRISPR Mediated Inflammatory Cytokine Receptor Modulation for the Treatment of Inflammatory Intervertebral Disc Pathology
$74,500Robert D. Bowles · University Of Utah · R03 · FY2015 · AR
Sequence-Specific CRISPR Mediated Inflammatory Cytokine Receptor Modulation for the Treatment of Inflammatory Intervertebral Disc Pathology
$74,500Robert D. Bowles · University Of Utah · R03 · FY2016 · AR
A Group B Streptococcus ordered CRISPR interference library to investigate host-pathogen interactions
$74,500Brandon Jonathan Kim · University Of Alabama In Tuscaloosa · R03 · FY2024 · AI
Sequence-Specific CRISPR Mediated Inflammatory Cytokine Receptor Modulation for the Treatment of Inflammatory Intervertebral Disc Pathology
$74,500Robert D. Bowles · University Of Utah · R03 · FY2017 · AR
Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion
$74,445Qizhi Tang · University Of California, San Francisco · R01 · FY2024 · DK